TrialJournal of atherosclerosis and thrombosis2023

Efficacy and Safety of Pemafibrate Versus Bezafibrate to Treat Patients with Hypertriglyceridemia: A Randomized Crossover Study.

Akihiro Nakamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.